Knowledge enterprise

GenCure, UTSA sign agreement for cell therapy collaboration

Retrieved on: 
Wednesday, December 20, 2023

The agreement between GenCure and the UTSA Stem Cell Core Lab includes two major areas.

Key Points: 
  • The agreement between GenCure and the UTSA Stem Cell Core Lab includes two major areas.
  • The agreement is an expansion of the relationship between the UTSA Stem Cell Core Lab and GenCure.
  • The UTSA Stem Cell Core also works to reduce the barriers to investigators who want to enter this specialized research field.
  • The UTSA Stem Cell Core is part of the UTSA Research, Economic Development, and Knowledge Enterprise (REDKE).

National Institutes of Health To Locate Signature Research Program on the Phoenix Bioscience Core

Retrieved on: 
Friday, September 15, 2023

PHOENIX, Sept. 15, 2023 /PRNewswire/ -- Wexford Science & Technology, LLC today announced that the National Institutes of Health has signed a lease at 850 PBC and will use the space to accommodate the Phoenix Epidemiology & Clinical Research Branch of the NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).  This innovative basic, translational, and clinical research center will occupy the entire 7th floor of 850 PBC, comprising approximately 35,000 square feet.

Key Points: 
  • "We are thrilled to announce the expansion of National Institutes of Health - NIDDK on the Phoenix Bioscience Core at 850 PBC," said Kyle Jardine, Market Executive at Wexford Science & Technology.
  • "NIH is a key research catalyst for our existing tenants, and reaffirms the PBC as Arizona's central hub for life science research and entrepreneurship.
  • The new lease at 850 PBC will allow all sections of NIDDK Phoenix to be co-located in the Phoenix Bioscience Core.
  • "It's an incredible win for Phoenix that more members of the NIDDK team will join our Phoenix Bioscience Core," City of Phoenix Mayor Kate Gallego said.